1. Total flavonoids from Plumula Nelumbinis suppress angiotensin II-induced fractalkine production by inhibiting the ROS/NF-κB pathway in human umbilical vein endothelial cells
   YONGWEN CAO et al, 2014, Experimental and Therapeutic Medicine CrossRef
2. A Low Fixed-dose Combination of Olmesartan and Azelnidipine Significantly Improves Endothelial Function in Uncontrolled Hypertension by Low Dose Amlodipine
   Bonpei Takase et al, 2013, Journal of the Japanese Coronary Association CrossRef
3. A Combination of Dexmedetomidine and Lidocaine Is a Cardiovascularly Safe Dental Local Anesthetic for Hypertensive Rats Treated With a Nonselective β-Adrenergic Antagonist
   Yukako Tsutsui et al, 2017, Anesthesia Progress CrossRef
4. Complexation of the Antihypertensive Drug Olmesartan with Zn: In Vivo Antihypertensive and Cardiac Effects
   Andrés G. Restrepo Guerrero et al, 2024, Biological Trace Element Research CrossRef
5. Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease
   Martin C. Michel et al, 2016, Pharmacology & Therapeutics CrossRef
6. Drug Evaluation: Olmesartan Medoxomil + Rosuvastatin for the Treatment of Dyslipidemia and Concomitant Risk Factors: A Chance for Better Compliance?
   Joanna Gozdzikiewicz-Lapinska et al, 2015, Combination Therapy In Dyslipidemia CrossRef
7. Antihypertensive Drugs Aliskiren, Nebivolol, and Olmesartan Reduce Hypertension by Reducing Endothelial Microparticles and Regulating Angiogenesis
   Moon Jain et al, 2017, Journal of Cardiovascular Pharmacology CrossRef